Early research (Phase 1)UnknownNCT03057912
What this trial is testing
A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ
Who this might be right for
Human Papillomavirus-Related Malignant Neoplasm
First Affiliated Hospital, Sun Yat-Sen University 60